A high expression of carbonyl reductase 1 (CBR1) in ovarian cancer is associated with good prognosis, Kobayashi et al. (2015) employed a gene therapy with CBR1 DNA and PAMAM dendrimer. Here, CBR1 is linked to ovarian cancer.